Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Carcinoma, Non-small-cell Lung · Type 2 Diabetes Mellitus · LGND

LIGAND PHARMACEUTICALS

LIGAND PHARMACEUTICALS INC

LIGAND PHARMACEUTICALS trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
555 Heritage Dr, Suite 200, Jupiter, Florida 33458, US HQ
1987 Founded
130 Employees
Public company Type
LGND · NYSE Ticker
Company details
Status
Public
HQ
555 Heritage Dr, Suite 200, Jupiter, Florida 33458, US
Founded
1987
Employees
130
Programs
34
Drugs
25
Patents
133
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

LIGAND PHARMACEUTICALS clinical trials

Registry index of 38 ClinicalTrials.gov studies linked to LIGAND PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

LIGAND PHARMACEUTICALS trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for LIGAND PHARMACEUTICALS.

  1. Ramipril tablet 10 mg — Phase 1

    Clinical update

  2. Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg — Phase 1

    Clinical update

  3. ONTAK (denileukin difitox, DAB389IL-2) — Approved

    Clinical update

  4. Intravenous Carbamazepine (IV CBZ) — Phase 3

    Clinical update

  5. erlotinib (Tarceva) and bexarotene (Targretin) — Unknown

    Clinical update

  6. erlotinib and bexarotene — Phase 2

    Clinical update

  7. Budesonide — Phase 2

    Clinical update

  8. Budesonide + Azelastine — Phase 2

    Clinical update

Trial registry

38 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.